This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-005446-jr3yj4o2 | A pilot study of continuous infusion heparin for the prevention of hepatic veno- occlusive disease after bone marrow transplantation Prophylactic heparin does not prevent liver veno- occlusive disease following autologous bone marrow transplantation Prevention of hepatic venoocclusive disease after bone marrow transplantation by continuous infusion of low- dose heparin: a prospective randomized trial Prevention of venoocclusive disease of the liver after bone marrow transplantation: heparin or no heparin? |
| cord-017302-xez0zso3 | a new therapeutic prospect in critical ill patients? |
| cord-018319-tylkbh4h | Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons? |
| cord-254183-98o0dssj | Xenotransplantation- associated infectious risk: a WHO consultation Rare and emerging viral infection in the transplant population Usutu virus infection in a patient who underwent orthotropic liver transplantation Viral metagenomics Viral discovery and sequence recovery using DNA microarrays Metagenomics and future perspectives in virus discovery From orphan virus to pathogen: the path to the clinical lab Next- generation sequencing and its applications in molecular diagnostics Virus identification in unknown tropical febrile illness cases using deep sequencing A new arenavirus in a cluster of fatal transplant- associated diseases History of discoveries and pathogenicity of TT viruses Human bocavirus: passenger or pathogen in acute respiratory tract infections? |
| cord-322606-cx6eh0ff | Does isochromosome 7q mandate bone marrow transplant in children with Shwachman- Diamond syndrome? |
| cord-006856-b1w25ob5 | P21 FTY720 interferes with effector functions and downregulates protein expression of S1P1 and S1P4 in human dendritic cells tures with FTY720/ FTY720-P- treated DC illustrated a cytokine production profile with a lower IFN-?( 22% vs. 25% relative reduction) and a higher IL-4( 64% vs. 92% relative increase), indicating a shift from Th1 toward Th2 differentiation as previously evinced for S1P. DC yields, phenotypic differentiation into iDC and mDC( besides a minor reduction in CD18 surface expression), as well as the investigated mechanisms of iDC antigen uptake( bacterial phagocytosis, mannose receptor- mediated, and fluid- phase endocytosis), were not affected at therapeutically relevant concentrations. |
| cord-018302-lmly43rd | hematopoietic cell transplant recipients Comparison of nasopharyngeal fl ocked swabs and nasopharyngeal wash collection methods for respiratory virus detection in hospitalized children using real- time polymerase chain reaction Implementation of fi lmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care Comparison of three commercial RT- PCR systems for the detection of respiratory viruses Evaluation of quantitative and type- specifi c real- time RT- PCR assays for detection of respiratory syncytial virus in respiratory specimens from children Application of TaqMan low- density arrays for simultaneous detection of multiple respiratory pathogens Detection and quantifi cation of human metapneumovirus in pediatric specimens by real- time RT- PCR Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes Evaluation of R- Mix FreshCells in shell vials for detection of respiratory viruses Rapid detection of respiratory viruses by shell vial culture and direct staining by using pooled and individual monoclonal antibodies Clinically useful method for the isolation of respiratory syncytial virus Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofl uorescent- antibody test Nosocomial transmission of respiratory syncytial virus in immunocompromised adults Antigenic and nucleic acid analysis of nosocomial isolates of respiratory syncytial virus Molecular characterization of strains of respiratory syncytial virus identifi ed in a hematopoietic stem cell transplant outpatient unit over 2 years: community or nosocomial infection? |
| cord-018339-tyrlpl94 | further insight- new perspectives? |
| cord-030921-wydk9p93 | a promising anti- graft versus host disease prophylaxis: where do we stand? |
| cord-014712-5u4e00q6 | DO WE STAND NOW? |
| cord-272835-6nx4f8ss | Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient A case of adenovirus viremia in a pediatric liver transplant recipient with neutropenia and lymphopenia: who and when should we treat? |
| cord-279638-jr1mbh7s | : a pilot single institution report Extracorporeal photochemotherapy in graft- versus- host disease: a longitudinal study on factors influencing the response and survival in pediatric patients Extracorporeal photochemotherapy as second- or first- line therapy of acute GVHD? |
| cord-279638-jr1mbh7s | we offer selective immune control without generalized immunosuppression? |
| cord-347761-wgodcsav | In investigation of the steady- state pharmacokinetics of oral valaciclovir in immunocompromised children Epidemiology of invasive candidiasis: a persistent public health problem Variation in policies for the management of febrile neutropaenia in United Kingdom Children's cancer Study Group centres Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation Human bocavirus: passenger of pathogen in acute respiratory tract infections? |
| cord-281026-2avisuge | Official Statement of The European Respiratory Society Lung function in children and adolescents: methods and reference values Immunomodulatory activity and effectiveness of macrolides in chronic airway disease Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft- versus- host disease? |
| cord-281026-2avisuge | The respiratory viruses connection: myth or reality? |
| cord-017883-6a4fkd5v | Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee( HICPAC) Management of fever in neutropenic patients with different risks of complications Repeated blood cultures in pediatric febrile neutropenia: would following the guidelines alter the outcome? |
| cord-017883-6a4fkd5v | a time series analysis Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective High rates of potentially infectious exposures between immunocompromised patients and their companion animals: an unmet need for education Pet ownership in immunocompromised children-- a review of the literature and survey of existing guidelines Should immunocompromised patients have pets? |
| cord-015389-vwgai4k9 | C allow a long- term hematopoietic reconstitution and clinical course even if storage is greater than 6 months? |
| cord-015389-vwgai4k9 | Can type of delivery infl uence cord blood units'quality? |
| cord-015389-vwgai4k9 | The disease free survival in this small cohort of high risk patients with t- FL is encouraging but needs longer follow- up Rituximab or not? |
| cord-015922-5wwy0m2k | Mycoses Study Group Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation Torsades de pointes associated with voriconazole use Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy Posaconazole or fluconazole for prophylaxis in severe graft- versus- host disease Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia Prophylaxis and aspergillosis- has the principle been proven? |
| cord-015922-5wwy0m2k | Should vascular catheters be removed from all patients with candidemia? |
| cord-015922-5wwy0m2k | an international consensus Should the consensus guidelines'specific criteria for the diagnosis of invasive fungal infection be changed? |
| cord-018209-v2crgj5w | Bone Marrow Transplantation Team Trends in the postmortem epidemiology of invasive fungal infections at a university hospital Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/ Mycosis Study Group( EORTC/ MSG) criteria be revised? |
| cord-018209-v2crgj5w | What Has Been Learned from Postmortem Studies? |
| cord-348130-t9tysvr8 | : how do we prevent and treat them? |
| cord-348130-t9tysvr8 | Cancer or resistant pathogens? |
| cord-005478-5iu38pr6 | These results warrant prospective comparative trials of PTCy versus standard use of ATG- based GVHD Disease status: CR1 Disclosure: Nothing to declare O178 Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? |
| cord-005478-5iu38pr6 | https://www.clinicaltrials.gov/ct2/show/NCT01560182? |
| cord-294906-1m4h116m | ( COVID-19) Outbreak in China Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-294906-1m4h116m | Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus COVID-19 Coronavirus Pandemic Effectiveness and safety of antiviral or antibody treatments for coronavirus COVID-19 virus and children: What do we know? |
| cord-322822-z0ehfrg0 | Community respiratory viral infection in adult lung transplant recipients Community respiratory virus infections following lung transplantation Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome Parainfluenza virus type 3 infections in hematopoietic stem cell transplant recipients: response to ribavirin therapy Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection- myth or reality? |
| cord-322822-z0ehfrg0 | Prolonged shedding of multidrug- resistant influenza A virus in an immunocompromised patient Parainfluenza and influenza virus infection in pediatric organ transplant recipients Influenza virus infection in adult solid organ transplant recipients Influenza B virus infection in pediatric solid organ transplant recipients Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients Use of oseltamivir to control influenza complications after bone marrow transplantation Adenovirus infection in adult orthotopic liver transplant recipiviral pneumonias in transplant recipients ents: incidence and clinical significance Adenovirus pneumonia in lung transplant recipients Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? |
| cord-005480-yg7salqt | What to do when the first allogeneic stem cell transplantation fails? |
| cord-005480-yg7salqt | Why is important to built a paediatric nurse group inside PDs WP? |
| cord-003866-3gwbc7z9 | ( not just exacerbate) periodontitis? |
| cord-003866-3gwbc7z9 | Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review Fusobacterium nucleatum, a new invasive pathogen in neutropenic patients? |
| cord-003866-3gwbc7z9 | Bacterial infections of the oral mucosa Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient Mucosa or skin as source of coagulase- negative staphylococcal bacteraemia? |
| cord-024651-578c9ut5 | A Promising Approach For Non- CGD Primary Immune Deficiencies Requiring Myeloablation? |
| cord-024651-578c9ut5 | p.? |
| cord-009997-oecpqf1j | Questions addressed their current feeding route and perception, for example,"What aspect(s) of tube feedings are beneficial to you?" |
| cord-009997-oecpqf1j | The question remains: which mechanisms influence platelet immune function and are they developmentally regulated? |
| cord-009997-oecpqf1j | and"What aspect(s) of tube feeding worry or scare you? |
| cord-004675-n8mlxe7p | ; and whether the information is actionable( clinical utility)? |
| cord-004675-n8mlxe7p | ; whether a given variant is causative( pathogenicity)? |
| cord-004675-n8mlxe7p | Through the sharing of genetic and health data, ClinGen seeks to answer whether a given gene is associated with a disease( clinical validity)? |
| cord-339931-e2ylkonb | How do we choose the best donor for T- cell- replete, HLA- haploidentical transplantation? |
| cord-339931-e2ylkonb | The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion? |
| cord-339931-e2ylkonb | The risk of polyomavirus BK- associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD Incidence, clinical outcome, and management of virus- induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation Hemorrhagic cystitis- a manifestation of graft versus host disease? |
| cord-313474-1gux1gsi | ( n ¼ 1 Introduction: Our previous research has provided the evidence that an autoreactive immune system can be? |
| cord-313474-1gux1gsi | ( range) Time to Minimum On- tx( days) Proportion? |
| cord-313474-1gux1gsi | reset? |
| cord-005460-ezrn8cva | Any role of high- dose chemotherapy in mediastinal nonseminoma germ cell tumors? |
| cord-005460-ezrn8cva | Gut microbiota and hematopoietic stem cell transplantation: where do we stand? |
| cord-005460-ezrn8cva | Is it feasible? |
| cord-005460-ezrn8cva | To wash or not to wash? |
| cord-006466-e1phpqes | ; Full- body magnetic resonance imaging demonstrates generalized lymphadenomegaly and hepatosplenomegaly; PET- CT showing signs of hypoperfusion in temporal( right), occipital and cerebellum regions( suggestive of hypoperfusion-vasculitis?) |
| cord-006466-e1phpqes | A( p.=?) of unknown significance and a MEFV heterozygous variant. |
| cord-006466-e1phpqes | Acute pneumonia? |
| cord-006466-e1phpqes | Moderate diffuse changes in the renal parenchyma( toxic- inflammatory?). |
| cord-014976-546zaoxn | Are peak level measurements of cyclosporin A useful in allogeneic stem cell transplantation? |
| cord-014976-546zaoxn | How much change in quantitative chimerism values is enough for clinical significance? |
| cord-014976-546zaoxn | The case raises a number of important questions regarding the biological implications of chimerism values, such as: 1) is 10% a relative or absolute figure; 2) is there a minimum/ threshold chimerism value for functionality of the graft in these metabolic diseases; 3) do all patients have the same% chimerism interval/ differential and threshold? |
| cord-014976-546zaoxn | Why will an amotosalen- based protocol for extracorporeal photopheresis be valuable? |
| cord-014976-546zaoxn | how to learn from artefacts? |
| cord-005487-vac061r8 | : do we need a randomized study? |
| cord-005487-vac061r8 | And fi nally, is DCL also observed as a very late complication of hematopoietic stem cell transplantation? |
| cord-005487-vac061r8 | How is the incidence of DCL evolving? |
| cord-005487-vac061r8 | Is development of DCL associated with viral status before and viral reactivation/ infection during as well as after transplantation? |
| cord-005487-vac061r8 | Is the risk of malignant transformation of grafted cells increasing with donor age? |
| cord-005487-vac061r8 | Is there any association with the form and extent of pretreatment( radiotherapy and chemotherapy) implicating a role of damaged microenvironment in the development of DCL? |
| cord-005487-vac061r8 | Is there any infl uence of graft source and donor type( bone marrow vs. peripheral blood stem cells vs. cord blood and related vs. unrelated)? |
| cord-005487-vac061r8 | While convention dictates that MRD is preferred over MUD, does this wisdom hold in RIC SCT? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare In haploidentical transplants is the incidence of acute and chronic GVHD strictly related to the stem cell source? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare P620 Does body mass index( BMI) pose a risk to outcome for pediatric non- infantile patients undergoing hematopoietic cell transplantation( HSCT)? |
| cord-005453-4057qib7 | Disclosure: Nothing to declare Pre- and- post magnetic resonance imaging of hips and knees for detecting osteonecrosis in children undergoing hematopoietic cell transplantation: In whom is it necessary? |
| cord-005453-4057qib7 | Disclosure: Nothing to disclose Is there any impact of the uric acid levels during the preand early post- graft infusion period, on the GVHD occurence and allotransplant outcome? |
| cord-005453-4057qib7 | Do we need to freeze hematopoietic cells for autotransplants in patients with myeloma conditioned with melphalan? |
| cord-005453-4057qib7 | Is fungal prophylaxis necessary in non myeloablative peripheral blood stem cell allogeneic transplantation in the pre- engrafment period? |
| cord-005453-4057qib7 | Is it really GVHD? |
| cord-005453-4057qib7 | Nothing to declare Is mobilization with chemotherapy effect response in the multiple myeloma? |
| cord-005453-4057qib7 | Nothing to declare Is there any association between thrombotic risk factors and veno- oclusive disease in childhood allogeneic hematopoietic stem cell transplantation? |